Key result
Bioinformatic analysis links CHD susceptibility genes to lipid metabolism, complement system, and endothelial function pathways.
Why the study?
Coronary heart disease development is mediated by genetic and environmental factors, prompting analysis of how susceptibility genes are involved in signaling and metabolic pathways.
Bioinformatic analysis reveals that CHD susceptibility genes are involved in multiple signaling and metabolic pathways related to lipid metabolism, endothelial function, and thrombosis.
Pathway insights from CHD gene analysis are hypothesis-generating; prospective human studies needed before clinical translation.
Coronary heart disease (CHD) is a common pathology, and its development is mediated by a large number of genetic factors, environmental factors, and their combinations. In this regard, the objective of the study was a bioinformatic analysis of the involvement of susceptibility genes to CHD in the implementation of signaling and metabolic pathways. The list of susceptibility genes was compiled using GWAS, DisGeNET, and GeneCards databases. Pathway enrichment analysis was performed using the ClueGO v2.5.9 Cytoscape v3.9.1 plugin. As a result of the study, it was established that these genes are involved in the implementation of various mechanisms of development of CHD, including disorders of lipid metabolism, changes in the activity of elements of the complement system, and endothelial function. Hereditary factors can influence changes in the processes of regulation of thrombus formation, vascular tone, the balance of pro- and antioxidant factors, endothelial permeability, and water and sodium adsorption, as well as the processes of angiogenesis. In this case, the genes under study may be involved in the implementation of one or several signaling/metabolic pathways.
No takes yet. Share an insight, caveat, or question.
Chasovskikh et al. (2024) studied Coronary heart disease. Bioinformatic analysis was evaluated on Involvement in signaling and metabolic pathways. Bioinformatic analysis established that CHD susceptibility genes are involved in multiple signaling and metabolic pathways, including lipid metabolism, complement system, and endothelial function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: